43 articles, transcripts, and reports
Abbott Laboratories (NYSE: ABT) Q4 2019 Earnings Conference Call Jan. 22, 2020 Corporate Participants: Scott Leinenweber — Vice President of Investor Relations, Licensing and Acquisitions Miles D. White — Chairman…
Abbott Laboratories (NYSE: ABT) reported a marked increase in fourth-quarter earnings as the drugmaker’s strong product portfolio boosted sales in the key markets. The results…
Abbott Laboratories’ (NYSE: ABT) third quarter 2019 earnings came in line with the market’s projections, while sales missed the expectations. The pharma company reported adjusted…
